Steven Cohen's OLMA Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 307,890 shares of Olema Pharmaceuticals, Inc. (OLMA) worth $7.7 M, representing 0.01% of the portfolio. First purchased in 2021-Q1, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in OLMA, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2024, adding 3.21 M shares. Largest reduction occurred in Q1 2025, reducing 2.23 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Olema Pharmaceuticals (OLMA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Olema Pharmaceuticals (OLMA) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +62,472 | Add 25.46% | 307,890 | $25.00 |
| Q3 2025 | +245,418 | New Buy | 245,418 | $9.79 |
| Q2 2025 | -1.44 M | Sold Out | 0 | $0.00 |
| Q1 2025 | -2.23 M | Reduce 60.73% | 1.44 M | $3.76 |
| Q4 2024 | -16,548 | Reduce 0.45% | 3.67 M | $5.83 |
| Q3 2024 | +475,447 | Add 14.80% | 3.69 M | $11.94 |
| Q2 2024 | +3.21 M | New Buy | 3.21 M | $10.82 |
| Q3 2021 | -80,000 | Sold Out | 0 | $0.00 |
| Q2 2021 | -13,900 | Reduce 14.80% | 80,000 | $27.98 |
| Q1 2021 | +93,900 | New Buy | 93,900 | $33.18 |
Steven Cohen's Olema Pharmaceuticals Investment FAQs
Steven Cohen first purchased Olema Pharmaceuticals, Inc. (OLMA) in Q1 2021, acquiring 93,900 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Olema Pharmaceuticals, Inc. (OLMA) for 10 quarters since Q1 2021.
Steven Cohen's largest addition to Olema Pharmaceuticals, Inc. (OLMA) was in Q2 2024, adding 3,211,927 shares worth $34.75 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 307,890 shares of Olema Pharmaceuticals, Inc. (OLMA), valued at approximately $7.7 M.
As of the Q4 2025 filing, Olema Pharmaceuticals, Inc. (OLMA) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Olema Pharmaceuticals, Inc. (OLMA) was 3,687,374 shares, as reported at the end of Q3 2024.